TORONTO, May 14, 2021 /CNW/ - Peter Rands, Chief Executive Officer, Small Pharma Inc. ("Small Pharma" or "the Company") (TSXV: DMT), and his team joined Dani Lipkin, Director, Global Business Development TMX Group, to celebrate the Company's new listing on TSX Venture Exchange and open the market.
Small Pharma is a neuropharmaceutical company specialised in IP led development of novel treatments for mental health conditions, with a focus on depression. Small Pharma initiated a clinical program into DMT assisted therapy in February 2021. This program includes a Phase I/IIa trial on their lead candidate alongside development of a robust pipeline of proprietary preclinical assets. For more information visit https://www.smallpharma.co.uk/.
For Market Openings: Media may pick up a feed from the TOC (television operations centre) for all market open ceremonies. The feed is named TSX Transmit 1 (SD-SDI) and is produced at the TMX Broadcast Centre and sent live to the TOC. To pick up the feed via the Dejero network, please contact [email protected]. The client feature video will begin playing on the TMX media wall at approximately 9:27 a.m. ET and the markets will open with the sound of a siren at 9:30 a.m. ET
Date: Friday, May 14, 2021
Time: 9:00am - 9:30am
Place: Virtually Broadcast
SOURCE TSX Venture Exchange
![](https://rt.newswire.ca/rt.gif?NewsItemId=C8312&Transmission_Id=202105141100CANADANWCANADAPR_C8312&DateId=20210514)
MEDIA CONTACT: Peter Rands, Chief Executive Officer, Email: [email protected], Tel: +44 (0)2071 129118
Share this article